Session date: 
Wednesday, October 5, 2016 - 8:00am to 9:00am
Location: 
Wisconsin Diagnostic Lab Building
9200 West Wisconsin Avenue - 2nd Floor
Pathology Administration Conference Room 230
WI 53226
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.
Program Description: 

This educational activity is based on case presentations and subsequent small group discussions of patients with hematologic malignancies that are being evaluated, treated and followed in the Department of Hematology and Oncology, and that have diagnostic or follow-up material evaluated in the Division of Hematopathology.  The goal of this multimodality approach is to insure that the best patient care is being delivered by both Hematologists/Oncologists and Pathologists.

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this Live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of  Participation for Allied Health Professionals
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
Target audience: 
  • Hematologists
  • Oncologists
  • Hematopathologists
Learning objectives: 

For Hematologists/Oncologists:  By completing this activity, I will be able to:

  1. To improve my ability to appropriately order expensive ancillary diagnostic tests. 
  2. To improve and maintain my ability to recognize the salient morphologic, immunophenotypic, cytogenetic, and molecular features of common hematologic malignancies.

For Hematopathologists:  By completing this activity, I will be able to:

     1.  To maintain and update my knowledge of emergent therapeutic options and availability of clinical trials, and how they apply to patients diagnosed in our service.

     2.  To constantly update myself with the clinical practices of the Department of Hematology and Oncology, in order to continue to improve outcomes and provide optimal
          patient care.
Faculty & credentials: 
Planning Committee:
Horatiu Olteanu, MD, PhD
Associate Professor of Pathology
Ehab Atallah, MD
Associate Professor of Medicine
Laura Michaelis, MD
Associate Professor of Medicine
 

All persons in control of content have NO relevant financial relationships to disclosure.

In accordance with the ACCME® standard for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.

CME Coordinator Contact Information

Name: 
Molly Young
Phone number: 
+1 (414) 805-6987